Xogene, a leader in clinical trial transparency solutions, announced the official launch of Transcend, an AI platform built by experts who have managed thousands of transparency submissions for leading life sciences companies.
Transcend addresses the limitations clinical trial sponsors face with generic AI tools that lack industry knowledge. Built on 16 years of domain expertise and refined with 2,000+ public clinical trials, the platform’s agentic architecture mirrors the multi-step workflows that transparency professionals use. This enables Transcend to navigate complex study designs and regulatory nuances that cause other AI tools to produce inaccurate outputs.
Following extensive pilot testing with clinical trial sponsors, Transcend has proven it can address the capacity constraints facing transparency teams:
- Speed: 80%+ time savings compared to manual processes across transparency activities
- Accuracy: 98% extraction accuracy with 85% fewer compliance errors
- Cost savings: Up to 50% cost savings in 2026 disclosure operations
Purpose-Built for Transparency Capabilities
Transcend accelerates the full range of transparency and medical writing activities—from protocol registration to results posting, plain language summaries, safety documents, informed consent forms, and clinical study reports—with capabilities built to support expert users:
- Processes multiple source documents simultaneously with detailed logging of which sections inform each output
- Handles complex study designs with multiple arms and cohorts that generic AI tools miss
- Integrates organizational glossaries, writing guides, and quality frameworks
- Reduces QC review time by up to 50% through complete reasoning and source references
- Outputs directly to company-branded templates or registry-ready XML
“Our customers face mounting regulatory pressure from regulators worldwide while managing lean resources,” said Woo Song, CEO at Xogene. “Transcend was built by people who've managed thousands of transparency submissions—we know exactly what is needed to maintain quality while achieving the efficiency gains that make compliance processes sustainable. Our depth of domain knowledge is what enables Transcend to deliver production-ready results from day one.”
Transcend is currently deployed in pilot programs with 12 sponsors across multiple use cases and is available for production implementations.
Measured time savings include:
- Protocol registration: 16 hours reduced to 3 hours (80% reduction)
- Results posting: 60 hours reduced to 15 hours (75% reduction)
- Protocol amendments: 12 hours to 1.5 hours (88% reduction)
- Plain language protocol synopsis: 18 hours reduced to 3.5 hours (80% reduction)
- Plain language summary of results: 24 hours to 3 hours (88% reduction)
Transcend integrates with Xogene Prime, Reach, and project management tools like Jira, and operates in a secure AWS environment with AWS Bedrock. Client data is not used to train models.
For more information, visit https://www.xogene.com/
Founded in 2010, Xogene specializes in clinical trial transparency solutions, serving more than 45 leading pharmaceutical and life sciences companies. Xogene’s Transparency Cloud platform streamlines regulatory compliance processes across the disclosure lifecycle. Xogene’s disclosure services provide end-to-end support for protocol registration, results posting, and plain language summaries. Serving clinical trial transparency, regulatory affairs, and medical writing teams, Xogene combines domain expertise with innovation to address evolving disclosure requirements.